Patient-derived lymphomoids preserve the tumor architecture and allow to assess response to therapies in lymphoma
A. Santamaria-Martinez, J. Epiney, D. Srivastava, D. Tavernari, M. Varrone, D. Milowich, I. Letovanec, T. Krueger, R. Duran, G. Ciriello, A. Cairoli, E. Oricchio
This study develops lymphomoids from patient lymphoma samples to assess therapy response, showing consistency with clinical outcomes.
bioRxiv · Apr 15, 2024 · PreprintCancer Biology